Elevated Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Elevated Private Wealth's VRTX Position: Q2 2026 in Review
Elevated Private Wealth opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 628 shares worth $312K. The stake represents 0.3% of the portfolio and ranks #70 among its holdings. This is a return to the name: Elevated Private Wealth previously reported a position in VRTX as recently as Q4 2025.
Elevated Private Wealth first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $415K in Q4 2025. 1,752 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Elevated Private Wealth held 628 shares of Vertex Pharmaceuticals worth $312K as of Q2 2026.
- Vertex Pharmaceuticals was a new Elevated Private Wealth position in Q2 2026.
- Vertex Pharmaceuticals made up 0.3% of Elevated Private Wealth's portfolio in Q2 2026, its #70 holding.
- Elevated Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- Elevated Private Wealth's Vertex Pharmaceuticals position peaked at $415K in Q4 2025.
- 1,752 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Elevated Private Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.